ALX Oncology Holdings Inc. (ALXO)
NASDAQ·Healthcare·Biotechnology
$1.49
-7.19%
Mkt Cap $236.83M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$17.90
Range $1.50 – $38.00
Implied Upside
+1105.4%
Consensus $17.90 vs current $1.49
NASDAQ·Healthcare·Biotechnology
$1.49
-7.19%
Mkt Cap $236.83M
No recent rating data.
Price Target (7 analysts)
$17.90
Range $1.50 – $38.00
+1105.4%
Consensus $17.90 vs current $1.49